ClinicalTrials.govpublic full text
Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC
head and neck squamous cell carcinoma, neoadjuvant therapy, pd-l1, anlotinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 801961
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.